Chat
Ehlers-Danlos Syndrome Type VI Screen
0080351
Copy Utility
Ordering Recommendation
Initial test to diagnose or rule out Ehlers-Danlos Syndrome, Type VI A (kyphoscoliotic type). This testing is NOT recommended to screen for other types of EDS.
Mnemonic
EDS6
Methodology
High Performance Liquid Chromatography (HPLC)
Performed
Wed
Reported
6-14 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
First-morning urine is preferred.
Collect
Urine. First-morning void. Also acceptable: Random specimens.
Specimen Preparation
Transfer 4 mL urine to an ARUP Standard Transport Tube. (Min: 3 mL)
Storage/Transport Temperature
Frozen.
Unacceptable Conditions
Remarks
Stability
Ambient: Unacceptable; Refrigerated: 1 week; Frozen: 6 months
Reference Interval
| Age |
PYR |
DPYR |
Ratio DPYR/PYR |
|---|---|---|---|
| 0-11 months | Not applicable | Not applicable | 0.13-0.20 |
| 1-3 years | Not applicable | Not applicable | 0.18-0.24 |
| 4-9 years | Not applicable | Not applicable | 0.19-0.25 |
| 10-14 years | Not applicable | Not applicable | 0.17-0.27 |
| 15-19 years | Not applicable | Not applicable | 0.20-0.26 |
| 20 years and older | Not applicable | Not applicable | 0.23-0.29 |
Interpretive Data
Compliance Category
Laboratory Developed Test (LDT)
Note
For pyridinoline and deoxypyridinoline quantitative results, order Pyridinoline & Deoxypyridinoline by HPLC (0080342).
Hotline History
N/A
CPT Codes
82523
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0080352 | Pyridinoline, pmol/mL | 34367-3 |
| 0080353 | Deoxypyridinoline, pmol/mL | 27424-1 |
| 0080354 | EDS6 Ratio | |
| 0080357 | EDS6 Interpretation | 56850-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- EDS VI
- pyridinoline and deoxypyridnoline
Ehlers-Danlos Syndrome Type VI Screen
Feedback
